AuroBlog - Aurous Healthcare Clinical Trials blog
JULY 14, 2024
A large clinical trial in South Africa and Uganda has shown that a twice-yearly injection of a new pre-exposure prophylaxis drug gives young women total protection from HIV infection. The trial tested whether the six-month injection of lenacapavir would provide better protection against HIV infection than two other drugs, both daily pills.
pharmaphorum
JULY 14, 2024
Observational study finds lower risk of cognitive problems and nicotine dependence in diabetics using Novo Nordisk's Ozempic
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
AuroBlog - Aurous Healthcare Clinical Trials blog
JULY 14, 2024
As the Union Budget approaches, the life sciences sector anticipates substantial support to enhance innovation and investment in the development of new chemical entities (NCEs) and new biological entities (NBEs). These initiatives are crucial for sustaining the sector’s growth trajectory and enhancing its global competitiveness.
pharmaphorum
JULY 14, 2024
Shares in Immutep shoot up after its LAG-3 inhibitor eftilagimod alfa revs up MSD's Keytruda in PD-L1-negative head and neck cancer
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Drug Patent Watch
JULY 14, 2024
This chart shows the drugs with the most patents in Austria. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.
BioSpace
JULY 14, 2024
Cell therapy biotech Artiva Biotherapeutics plans to use the funds raised to support the development of its AlloNK therapy for systemic lupus erythematosus.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
BioSpace
JULY 14, 2024
After a busy first half of 2024, several companies are expecting key data readouts in the neuropsychiatric and neurodegenerative disease spaces during the next six months.
JAMA Internal Medicine
JULY 14, 2024
This cohort study evaluates marketing payments from pharmaceutical and medical device manufacturers to physician trainees before and after fellowship graduation.
BioSpace
JULY 14, 2024
Halia Therapeutics, NodThera and Gain Therapeutics target neuroinflammatory processes in hopes of modifying the course of Parkinson’s progression.
JAMA Internal Medicine
JULY 14, 2024
This essay describes the author’s experience with delivering life-and-death information to patients and families in the intensive care unit.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
BioSpace
JULY 14, 2024
SignalChem Biotech, World Leader in Kinases, Is Now Part of Sino Biological - read this article along with other careers information, tips and advice on BioSpace
JAMA Internal Medicine
JULY 14, 2024
This Viewpoint compares use and costs of glucagon-like peptide 1 (GLP-1) receptor agonists for weight loss between the US and 3 other peer countries.
BioSpace
JULY 14, 2024
Why I advocated on Capitol Hill this month for the renewal of the FDA’s Priority Review Voucher program
Expert insights. Personalized for you.
246 
Let's personalize your content